NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Buyer Name: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Buyer Address: 4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw, Cardiff, UK, CF15 7QZ, United Kingdom
Contact Email: gregg.roberts@wales.nhs.uk
The MHLD Directorate are seeking approval to recommission the inpatient substance misuse detoxification service for North Wales. The inpatient substance misuse detoxification service is for patients who have physical and/or psychological dependency to one or more substances with physical or psychiatric complications (co-morbidity) if they require a higher level of care than can be provided safely in the community. North Wales is an outlier in several areas for substance misuse as outlined. In 2022/2023, 19 of the 22 Local Authority areas in Wales saw a decrease in rates of individuals admitted to hospital with an alcohol-specific condition. The only 3 Local Authority areas that saw an increase were Gwynedd (4 per cent) Anglesey (7 per cent) and Wrexham (10 per cent). Betsi Cadwaladr University Health Board (BCUHB) area has the highest rate of admissions related to illicit drugs (152.1 per 100,000 population) across Wales. When looking at deaths from drug misuse for 2020-22 by local authority, Wrexham is in the top 5 local authorities with a population prevalence of 8.6 per 100,000 population compared with the Welsh average being 6.6 per 100,000 of the population. The number of patients referred for inpatient substance misuse detoxification service has steadily increased over the last three years. This is from 194 admissions in 2022, 227 admissions in 2023 and 183 in 2024 To ensure that the existing service delivery model is still fit for purpose a full options appraisal process has been undertaken following the Better Business case methodology and explored a range of potential options including BCUHB delivery and external procurement.
No linked documents found for this notice.
Lot Description: The MHLD Directorate are seeking approval to recommission the inpatient substance misuse detoxification service for North Wales. The inpatient substance misuse detoxification service is for patients who have physical and/or psychological dependency to one or more substances with physical or psychiatric complications (co-morbidity) if they require a higher level of care than can be provided safely in the community. North Wales is an outlier in several areas for substance misuse as outlined. In 2022/2023, 19 of the 22 Local Authority areas in Wales saw a decrease in rates of individuals admitted to hospital with an alcohol-specific condition. The only 3 Local Authority areas that saw an increase were Gwynedd (4 per cent) Anglesey (7 per cent) and Wrexham (10 per cent). Betsi Cadwaladr University Health Board (BCUHB) area has the highest rate of admissions related to illicit drugs (152.1 per 100,000 population) across Wales. When looking at deaths from drug misuse for 2020-22 by local authority, Wrexham is in the top 5 local authorities with a population prevalence of 8.6 per 100,000 population compared with the Welsh average being 6.6 per 100,000 of the population. The number of patients referred for inpatient substance misuse detoxification service has steadily increased over the last three years. This is from 194 admissions in 2022, 227 admissions in 2023 and 183 in 2024 To ensure that the existing service delivery model is still fit for purpose a full options appraisal process has been undertaken following the Better Business case methodology and explored a range of potential options including BCUHB delivery and external procurement. Please see Information for Bidders document on the Bravo Solutions portal for further details. Betsi Cadwaladr University Health Board recognises the importance of the Welsh language to the communities it serves. Consequently, responses to an invitation to quote or tender will be accepted in Welsh as well as English. However, please note that tender responses submitted only in Welsh will be translated by the Trust into English before consideration. Those involved in translating the document will be barred from taking decisions on awarding tenders. The tender will be awarded based on 30% cost & 70% quality as detailed in the ITT document. Please note that the tender closing date is 07/10/2025 at midday and any late submissions will not be considered. The etenderwales bravosolution ref:Project: project_59436 and itt_120050 Please direct all queries relating to this tender via the messaging function of the Bravo portal. More details can be found at https://etenderwales.bravosolution.co.uk.
Lot 1 Status: active
Lot 1 Has Options: No
{
"buyer": {
"id": "GB-FTS-109",
"name": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)"
},
"date": "2025-09-16T16:56:54+01:00",
"description": "NOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on Sell2Wales at https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=155749\n(WA Ref:155749)\nThe buyer considers that this contract is suitable for consortia.",
"id": "057084-2025",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-059ba5",
"parties": [
{
"address": {
"countryName": "United Kingdom",
"locality": "Cardiff",
"postalCode": "CF15 7QZ",
"region": "UK",
"streetAddress": "4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw"
},
"contactPoint": {
"email": "gregg.roberts@wales.nhs.uk",
"url": "https://etenderwales.bravosolution.co.uk/web/login.shtml"
},
"details": {
"buyerProfile": "https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221",
"classifications": [
{
"description": "Body governed by public law",
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE"
},
{
"description": "Health",
"id": "07",
"scheme": "COFOG"
}
],
"url": "http://nwssp.nhs.wales/ourservices/procurement-services/"
},
"id": "GB-FTS-109",
"identifier": {
"legalName": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)"
},
"name": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)",
"roles": [
"buyer",
"centralPurchasingBody"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "WC2A 2LL",
"streetAddress": "Royal Courts of Justice, The Strand"
},
"contactPoint": {
"telephone": "+44 2079477501"
},
"id": "GB-FTS-111",
"identifier": {
"legalName": "High Court"
},
"name": "High Court",
"roles": [
"reviewBody"
]
}
],
"tag": [
"tender"
],
"tender": {
"awardPeriod": {
"startDate": "2025-10-07T12:00:00+01:00"
},
"bidOpening": {
"date": "2025-10-07T12:00:00+01:00"
},
"classification": {
"description": "Rehabilitation services",
"id": "85312500",
"scheme": "CPV"
},
"communication": {
"atypicalToolUrl": "https://etenderwales.bravosolution.co.uk/web/login.shtml"
},
"contractTerms": {
"electronicInvoicingPolicy": "allowed",
"hasElectronicOrdering": true,
"hasElectronicPayment": true
},
"coveredBy": [
"GPA"
],
"description": "The MHLD Directorate are seeking approval to recommission the inpatient substance misuse detoxification service for North Wales.\nThe inpatient substance misuse detoxification service is for patients who have physical and/or psychological dependency to one or more substances with physical or psychiatric complications (co-morbidity) if they require a higher level of care than can be provided safely in the community.\nNorth Wales is an outlier in several areas for substance misuse as outlined.\nIn 2022/2023, 19 of the 22 Local Authority areas in Wales saw a decrease in rates of individuals admitted to hospital with an alcohol-specific condition. The only 3 Local Authority areas that saw an increase were Gwynedd (4 per cent) Anglesey (7 per cent) and Wrexham (10 per cent).\nBetsi Cadwaladr University Health Board (BCUHB) area has the highest rate of admissions related to illicit drugs (152.1 per 100,000 population) across Wales.\nWhen looking at deaths from drug misuse for 2020-22 by local authority, Wrexham is in the top 5 local authorities with a population prevalence of 8.6 per 100,000 population compared with the Welsh average being 6.6 per 100,000 of the population.\nThe number of patients referred for inpatient substance misuse detoxification service has steadily increased over the last three years. This is from 194 admissions in 2022, 227 admissions in 2023 and 183 in 2024\nTo ensure that the existing service delivery model is still fit for purpose a full options appraisal process has been undertaken following the Better Business case methodology and explored a range of potential options including BCUHB delivery and external procurement.",
"documents": [
{
"documentType": "economicSelectionCriteria",
"id": "economic"
},
{
"documentType": "technicalSelectionCriteria",
"id": "technical"
}
],
"hasRecurrence": true,
"id": "BCU-CP-59436",
"items": [
{
"additionalClassifications": [
{
"description": "Rehabilitation services",
"id": "85312500",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKL11"
},
{
"region": "UKL12"
},
{
"region": "UKL13"
},
{
"region": "UKL23"
}
],
"id": "1",
"relatedLot": "1"
}
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"lots": [
{
"contractPeriod": {
"durationInDays": 1080
},
"description": "The MHLD Directorate are seeking approval to recommission the inpatient substance misuse detoxification service for North Wales.\nThe inpatient substance misuse detoxification service is for patients who have physical and/or psychological dependency to one or more substances with physical or psychiatric complications (co-morbidity) if they require a higher level of care than can be provided safely in the community.\nNorth Wales is an outlier in several areas for substance misuse as outlined.\nIn 2022/2023, 19 of the 22 Local Authority areas in Wales saw a decrease in rates of individuals admitted to hospital with an alcohol-specific condition. The only 3 Local Authority areas that saw an increase were Gwynedd (4 per cent) Anglesey (7 per cent) and Wrexham (10 per cent).\nBetsi Cadwaladr University Health Board (BCUHB) area has the highest rate of admissions related to illicit drugs (152.1 per 100,000 population) across Wales.\nWhen looking at deaths from drug misuse for 2020-22 by local authority, Wrexham is in the top 5 local authorities with a population prevalence of 8.6 per 100,000 population compared with the Welsh average being 6.6 per 100,000 of the population.\nThe number of patients referred for inpatient substance misuse detoxification service has steadily increased over the last three years. This is from 194 admissions in 2022, 227 admissions in 2023 and 183 in 2024\nTo ensure that the existing service delivery model is still fit for purpose a full options appraisal process has been undertaken following the Better Business case methodology and explored a range of potential options including BCUHB delivery and external procurement.\nPlease see Information for Bidders document on the Bravo Solutions portal for further details.\nBetsi Cadwaladr University Health Board recognises the importance of the Welsh language to the communities it serves. Consequently, responses to an invitation to quote or tender will be accepted in Welsh as well as English. However, please note that tender responses submitted only in Welsh will be translated by the Trust into English before consideration. Those involved in translating the document will be barred from taking decisions on awarding tenders.\nThe tender will be awarded based on 30% cost \u0026 70% quality as detailed in the ITT document. Please note that the tender closing date is 07/10/2025 at midday and any late submissions will not be considered.\nThe etenderwales bravosolution ref:Project: project_59436 and itt_120050\nPlease direct all queries relating to this tender via the messaging function of the Bravo portal. More details can be found at https://etenderwales.bravosolution.co.uk.",
"hasOptions": false,
"hasRenewal": true,
"id": "1",
"renewal": {
"description": "an option to extend for two (2) further one (1) year periods, at the discretion of the Health Board and subject to supplier performance."
},
"status": "active",
"submissionTerms": {
"variantPolicy": "notAllowed"
}
}
],
"mainProcurementCategory": "services",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"recurrence": {
"description": "2028"
},
"status": "active",
"submissionMethod": [
"electronicSubmission"
],
"submissionMethodDetails": "https://etenderwales.bravosolution.co.uk/web/login.shtml",
"submissionTerms": {
"languages": [
"en",
"cy"
]
},
"tenderPeriod": {
"endDate": "2025-10-07T12:00:00+01:00"
},
"title": "BCU-CP-59436 - Detoxification Services",
"value": {
"amount": 5100000.0,
"currency": "GBP"
}
}
}